Lumina Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,000
Closed -$580K 13
2023
Q3
$580K Hold
10,000
0.2% 38
2023
Q2
$640K Hold
10,000
0.27% 41
2023
Q1
$693K Hold
10,000
0.33% 31
2022
Q4
$720K Hold
10,000
0.27% 27
2022
Q3
$711K Hold
10,000
0.27% 22
2022
Q2
$770K Hold
10,000
0.29% 23
2022
Q1
$730K Sell
10,000
-5,000
-33% -$336K 0.23% 29
2021
Q4
$935K Hold
15,000
0.29% 18
2021
Q3
$888K Hold
15,000
0.32% 17
2021
Q2
$1M Hold
15,000
0.46% 16
2021
Q1
$947K Hold
15,000
0.36% 17
2020
Q4
$930K Hold
15,000
0.39% 16
2020
Q3
$904K Hold
15,000
0.55% 15
2020
Q2
$882K Hold
15,000
0.51% 16
2020
Q1
$836K Hold
15,000
0.47% 13
2019
Q4
$963K Hold
15,000
0.47% 16
2019
Q3
$761K Hold
15,000
0.38% 22
2019
Q2
$680K Buy
+15,000
New +$699K 0.34% 25
2018
Q3
Sell
-107,200
Closed -$5.93M 36
2018
Q2
$5.93M Hold
107,200
0.59% 12
2018
Q1
$6.78M Hold
107,200
0.61% 14
2017
Q4
$6.57M Hold
107,200
0.61% 13
2017
Q3
$6.83M Hold
107,200
0.7% 12
2017
Q2
$5.97M Hold
107,200
0.39% 15
2017
Q1
$5.83M Sell
107,200
-8,800
-8% -$483K 0.73% 12
2016
Q4
$6.78M Buy
+116,000
New +$6.34M 0.72% 11

Other funds holding BMY

Lumina Fund Management's BMY Position: Q4 2023 in Review

Lumina Fund Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 10,000 shares — an estimated $580K sold.

Lumina Fund Management first reported a position in BMY in Q4 2016 and held it in 25 quarters. The position peaked at $6.83M in Q3 2017. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Lumina Fund Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Lumina Fund Management sold 10,000 Bristol-Myers Squibb shares in Q4 2023, an estimated $580K.
  • Lumina Fund Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 25 quarters.
  • Lumina Fund Management's Bristol-Myers Squibb position peaked at $6.83M in Q3 2017.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Lumina Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.